Peter Kalev
About Peter Kalev
Peter Kalev is a Principal Scientist/Associate Director at Bristol Myers Squibb in Greater Boston, with extensive experience in cancer biology, drug discovery, and DNA damage response.
Current Position at Bristol Myers Squibb
Peter Kalev is currently serving as the Principal Scientist/Associate Director at Bristol Myers Squibb. He started his role in October 2020 and operates from the Greater Boston Area. He leads a lab specializing in DNA damage response and drug discovery. His position involves significant research responsibilities and leadership within the organization, contributing to various advanced scientific projects.
Previous Role at Agios Pharmaceuticals
Prior to his current role, Peter Kalev worked at Agios Pharmaceuticals as a Senior Scientist. He held this position from 2015 to 2020, working for five years in Boston, Massachusetts, United States. During his tenure, he contributed to important scientific research in the biotech sector, focusing on innovative therapeutic solutions.
Postdoctoral Research at Dana-Farber Cancer Institute
Peter Kalev served as a Postdoctoral Research Fellow at Dana-Farber Cancer Institute from 2013 to 2015. During these two years, he was involved in research initiatives in the Greater Boston Area, focusing on cancer biology. This experience allowed him to deepen his expertise in oncology research.
Educational Background in Biomedical Sciences
Peter Kalev has an extensive educational background in the field of biomedical sciences. He completed a PhD at VIB in Leuven, Belgium, where he studied Oncology and Cancer Biology from 2009 to 2013. Additionally, he holds a Postdoc in Cancer Biology from Harvard University and a Master’s degree in Biochemistry from Sofia University St. Kliment Ohridski, where he studied Molecular Biology from 2001 to 2008.
Research Experience Across Institutions
Peter Kalev has accumulated significant research experience across various prestigious institutions. He was a Research Scientist at Leiden University Medical Center for one year (2008-2009) and a Research Fellow at the Bulgarian Academy of Sciences for two years (2006-2008). He also worked as a Project Trainee at Sofia University, Faculty of Microbiology, for two years (2004-2006), contributing to various scientific projects during these periods.